KOD – kodiak sciences inc (US:NASDAQ)

News

Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy [Yahoo! Finance]
Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy
Kodiak Sciences to Present at Glaucoma 360 New Horizons Forum 2025
Kodiak Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
KOD Stock Rallies 271% in 6 Months on Eye Disease Program Updates [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com